These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 12723401)

  • 1. [Synthetic studies of microbial natural products from microorganisms].
    Sunazuka T
    Jpn J Antibiot; 2003 Feb; 56(1):66-79. PubMed ID: 12723401
    [No Abstract]   [Full Text] [Related]  

  • 2. Total synthesis of alpha-pyrone meroterpenoids, novel bioactive microbial metabolites.
    Sunazuka T; Omura S
    Chem Rev; 2005 Dec; 105(12):4559-80. PubMed ID: 16351054
    [No Abstract]   [Full Text] [Related]  

  • 3. Design and synthesis of simple, yet potent and selective non-ring-A pyripyropene A-based inhibitors of acyl-coenzyme A: cholesterol acyltransferase 2 (ACAT2).
    Zhan Y; Zhang XW; Xiong Y; Li BL; Nan FJ
    Org Biomol Chem; 2016 Jan; 14(2):747-751. PubMed ID: 26584338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and Synthesis of A-Ring Simplified Pyripyropene A Analogues as Potent and Selective Synthetic SOAT2 Inhibitors.
    Ohtawa M; Arima S; Ichida N; Terayama T; Ohno H; Yamazaki T; Ohshiro T; Sato N; Omura S; Tomoda H; Nagamitsu T
    ChemMedChem; 2018 Mar; 13(5):411-421. PubMed ID: 29323466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemical modification and structure-activity relationships of pyripyropenes. 3. Synthetic conversion of pyridine-pyrone moiety.
    Obata R; Sunazuka T; Tian Z; Tomoda H; Harigaya Y; Omura S
    J Antibiot (Tokyo); 1997 Mar; 50(3):229-36. PubMed ID: 9127194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and structure-activity relationship of pyripyropene A derivatives as potent and selective acyl-CoA:cholesterol acyltransferase 2 (ACAT2) inhibitors: part 1.
    Ohtawa M; Yamazaki H; Ohte S; Matsuda D; Ohshiro T; Rudel LL; Omura S; Tomoda H; Nagamitsu T
    Bioorg Med Chem Lett; 2013 Mar; 23(5):1285-7. PubMed ID: 23369538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and synthesis of bridged gamma-lactams as analogues of beta-lactam antibiotics.
    Aszodi J; Rowlands DA; Mauvais P; Collette P; Bonnefoy A; Lampilas M
    Bioorg Med Chem Lett; 2004 May; 14(10):2489-92. PubMed ID: 15109638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and structure-activity relationship of pyripyropene A derivatives as potent and selective acyl-CoA:cholesterol acyltransferase 2 (ACAT2) inhibitors: part 3.
    Ohtawa M; Yamazaki H; Ohte S; Matsuda D; Ohshiro T; Rudel LL; Ōmura S; Tomoda H; Nagamitsu T
    Bioorg Med Chem Lett; 2013 Jul; 23(13):3798-801. PubMed ID: 23711919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and structure-activity relationship of pyripyropene A derivatives as potent and selective acyl-CoA:cholesterol acyltransferase 2 (ACAT2) inhibitors: part 2.
    Ohtawa M; Yamazaki H; Matsuda D; Ohshiro T; Rudel LL; Ōmura S; Tomoda H; Nagamitsu T
    Bioorg Med Chem Lett; 2013 May; 23(9):2659-62. PubMed ID: 23535327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Total syntheses of the antibacterial natural product abyssomicin C.
    Peters R; Fischer DF
    Angew Chem Int Ed Engl; 2006 Sep; 45(35):5736-9. PubMed ID: 16906621
    [No Abstract]   [Full Text] [Related]  

  • 11. Analgetically active substances derived from structures of anpirtoline and epibatidine.
    Rádl S; Hezký P; Proska J; Krejcí I
    Gen Physiol Biophys; 1998 Jun; 17 Suppl 1():26-9. PubMed ID: 9789748
    [No Abstract]   [Full Text] [Related]  

  • 12. Design, synthesis, and biological activities of madindoline analogues.
    Yamamoto D; Sunazuka T; Hirose T; Kojima N; Kaji E; Omura S
    Bioorg Med Chem Lett; 2006 May; 16(10):2807-11. PubMed ID: 16481161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and biological activity of polyalthenol and pentacyclindole analogues.
    Marcos IS; Moro RF; Costales I; Basabe P; Díez D; Gil A; Mollinedo F; Pérez-de la Rosa F; Pérez-Roth E; Padrón JM
    Eur J Med Chem; 2014 Feb; 73():265-79. PubMed ID: 24412720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in dearomatization of heteroaromatic compounds.
    Ding Q; Zhou X; Fan R
    Org Biomol Chem; 2014 Jul; 12(27):4807-15. PubMed ID: 24875150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selectivity of microbial acyl-CoA: cholesterol acyltransferase inhibitors toward isozymes.
    Ohshiro T; Rudel LL; Omura S; Tomoda H
    J Antibiot (Tokyo); 2007 Jan; 60(1):43-51. PubMed ID: 17390588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Total synthesis and biological evaluation of (-)apicularen A and analogues thereof.
    Nicolaou KC; Kim DW; Baati R; O'Brate A; Giannakakou P
    Chemistry; 2003 Dec; 9(24):6177-91. PubMed ID: 14679529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-activity relationships of pyripyropenes fungal acyl-CoA: cholesterol acyltransferase inhibitors.
    Obata R; Sunazuka T; Li Z; Tomoda H; Omura S
    J Antibiot (Tokyo); 1995 Jul; 48(7):749-50. PubMed ID: 7649883
    [No Abstract]   [Full Text] [Related]  

  • 18. Synthesis, antibacterial, and antiviral evaluation of new heterocycles containing the pyridine moiety.
    Salem MS; Sakr SI; El-Senousy WM; Madkour HM
    Arch Pharm (Weinheim); 2013 Oct; 346(10):766-73. PubMed ID: 24105721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-activity relationships of lactacystin, the first non-protein neurotrophic factor.
    Nagamitsu T; Sunazuka T; Stump H; Obata R; Arima S; Matsuzaki K; Tanaka H; Omura S
    J Antibiot (Tokyo); 1995 Jul; 48(7):747-8. PubMed ID: 7649882
    [No Abstract]   [Full Text] [Related]  

  • 20. Total synthesis of abyssomicin C, atrop-abyssomicin C, and abyssomicin D: implications for natural origins of atrop-abyssomicin C.
    Nicolaou KC; Harrison ST
    J Am Chem Soc; 2007 Jan; 129(2):429-40. PubMed ID: 17212423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.